Navigation Links
National Stem Cell Holding, Inc. (Ticker NHGI) Subsidiary Proteoderm, Inc. Debuts Cosmoceutical Line at the 2008 World Congress on Anti-Aging Medicine
Date:7/17/2008

MOUNTAINSIDE, N.J., July 17 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (OTC: NHGI) today announced that its wholly owned subsidiary Proteoderm, Inc. is exhibiting at the 16th Annual International World Congress on Anti-Aging Medicine being held in Washington, DC on July 17 -- 19, 2008. Dr. Kenneth Steiner, MD, MBA was invited to speak as a scientific keynote panelist. Dr. Steiner will introduce the company's first commercial line of cosmoceuticals, which will be sold through medical sales representatives for use by dermatologists, plastic surgeons and other licensed health care professionals.

Proteoderm licenses patented technologies involving stem cells and their derivatives developed by National Stem Cell Holding, Inc. Proteoderm produces, designs and synthesizes proteins, polypeptides and growth hormones secreted by stem cells trademarked under Secreted Matrix(TM) and Matrix NC 138(TM) and incorporates them into uniquely formulated personal care products.

Proteoderm has created an anti-aging and anti-wrinkle product line that enhances the skin's firmness and elasticity and promotes the skin's natural moisture production activity. Unlike the array of products on the market today that reduce the appearance of wrinkles by artificial moisturizing and plumping, Proteoderm's products are the first to provide Matrix NC 138(TM) to the skin surface. Proteoderm's cosmoceutical kits will contain day and night creams and an under-eye serum containing the patented Matrix NC 138(TM) as well as an exfoliant and a cleanser.

Dr. Steiner stated, "During pregnancy, the human body increases the production specific proteins in response to secretions produced by stem cells. These specific proteins are known to effect specific receptors in the skin that enhance the production of facial collagen. Proteoderm has developed compositions including topical formulations containing these naturally occurring proteins which assist in counteracting the adverse consequences of aging."

"We are very excited to commercialize Proteoderm's first line of cosmoceuticals. We look forward to enhancing shareholders' value as we introduce our unique product. This is a turning point in the maturation of our company," said CEO of National Stem Cell Holding, Inc. Michael Cohen.

TO LEARN MORE ABOUT OUR PRODUCTS VISIT HTTP://WWW.PROTEODERM.COM.

About National Stem Cell Holding, Inc.

National Stem Cell Holding, Inc. is a biotechnology company focused on the development and commercialization of cell therapeutics primarily for diabetes and cardiac disease, and cosmetics derived from stem cells. For more information, visit http://www.proteoderm.com, and http://www.proteonomix.com.

"Safe Harbor Statement"

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products and products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact:

Michael Cohen

Phone: (973) 544-6116

info@nationalstemcell.com


'/>"/>
SOURCE National Stem Cell Holding, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 25, 2017 , ... ... process behind each occurrence. Live cell imaging using fluorescence microscopy is the perfect ... of automated fluorescence microscopy methods will be discussed, from small animal models and ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... treasurer for the Mid-Atlantic chapter of the Healthcare Businesswomen’s Association (HBA). ... The HBA Mid-Atlantic chapter board meets in person once each quarter and holds ...
(Date:5/24/2017)... (PRWEB) , ... May 23, ... ... Northeast's premier provider of high quality relocatable and permanent modular buildings, announced ... visual management tools and modern office design characteristics to help support on-site ...
(Date:5/24/2017)... Austin, TX May 24, 2017 (PRWEB) , ... ... ... Require Constant Connectivity , Medical systems are increasingly being developed with Wi-Fi connectivity ... to be easily moved from room to room. In addition, compact mobile devices ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
Breaking Biology News(10 mins):